• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 71020
Device Problems Malposition of Device (2616); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inadequate Pain Relief (2388); Post Operative Wound Infection (2446)
Event Date 07/23/2023
Event Type  Injury  
Manufacturer Narrative
There are no allegations of system or component failure.Malposition of the implanted leads is related to physician technique in performing the implant and attempting to place the implanted components in a comfortable location for the patient.Review of applicable device history records did not identify any excursions that are likely to have contributed to infection.Infection is a known inherent risk of invasive procedures.
 
Event Description
Patient presented with a preexisting neuroma at the knee where the nalu system was planned for implant.During the trial phase of the implant the patient reported that the implanted components were causing some discomfort at the neuroma.When the patient was implanted with the permanent peripheral nerve stimulator system the physician chose a slightly different location for implant in order to avoid discomfort at the neuroma location.During initial programming the patient reported feeling stimulation in a different area than was targeted and conclusion by the medical staff was that the placement of the implanted leads was improper.On (b)(6) 2023 the patient notified medical staff that they had been seen in an urgent care facility with a diagnosis of infection at the surgical site.A full system explant was performed on (b)(6) 2023 due to combination of suboptimal lead placement and infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad
Manufacturer Contact
terry villarba
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key17600555
MDR Text Key321712335
Report Number3015425075-2023-00190
Device Sequence Number1
Product Code GZF
UDI-Device Identifier00812537036182
UDI-Public01008125370361821122030117250301
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number71020
Device Catalogue Number71020
Device Lot NumberA03605
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/01/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-